O.101 A novel primboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg+ chronic hepatitis B: A phase IIa clinical trial

✍ Scribed by J. Schneider; W. Halota; D. Delic; Z. Nesic; D. Prokopowicz; R. Flisiak; J. Kuydowicz; M. Jablkowski; J. Cianciara; T. Mach; R. Modrzewska; M. Fabri; D. Tomic; A. Horban; W. Krycka; M. Cripps

• Book ID: 117770138
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 146 KB
• Volume: 36
• Category: Article
• ISSN: 1386-6532
• DOI: 10.1016/s1386-6532(06)80097-1